Research has shown that DLC1, as a gene from the same family as GMIP, acts as a tumour suppressor in hepatocellular carcinoma and provides evidence supporting the hypothesis that DLC1 inhibits cancer cell growth by negatively regulating Rho protein activity [12, 17]. Here, DLC1 is linked to hepatocellular carcinoma.